Cargando…
The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression
Although androgen-deprivation treatment (ADT) is the main treatment for advanced prostate cancer (PCa), it eventually fails. This failure invariably leads to castration-resistant prostate cancer (CRPC) and the development of the neuroendocrine (NE) phenotype. The molecular basis for PCa progression...
Autores principales: | Liu, Hui, Wu, Zhen, Zhou, Haibin, Cai, Wenjie, Li, Xinjun, Hu, Jing, Gao, Lin, Feng, Tingting, Wang, Lin, Peng, Xijia, Qi, Mei, liu, Long, Han, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593351/ https://www.ncbi.nlm.nih.gov/pubmed/31238254 http://dx.doi.org/10.1016/j.neo.2019.05.007 |
Ejemplares similares
-
The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential
por: Dal Bo, Michele, et al.
Publicado: (2015) -
The miR-17-92 cluster/QKI2/β-catenin axis promotes osteosarcoma progression
por: Yang, Hongbo, et al.
Publicado: (2018) -
miR-17 acts as a tumor suppressor by negatively regulating the miR-17-92 cluster
por: Sweat, Yan, et al.
Publicado: (2021) -
Roles of miR-17-92 Cluster in Cardiovascular Development and Common Diseases
por: Gu, Huanyu, et al.
Publicado: (2017) -
Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2015)